FOR GROWTH HORMONE THERAPY, NOW AVAILABLE IN THE U.S. -- Device is designed for patients' ease of daily use, reliability and convenience--
Today's launch of easypod(R) by EMD Serono, Inc. marks an advancement in the use of technology in growth hormone delivery devices.
The first of its kind device in this therapeutic area, easypod(R) was designed for ease of daily use, reliability and convenience. easypod(R) was the recipient of a 2007 Gold Medal from the Medical Design Excellence Awards(R), a premier awards program for the medical technology community.
Key features include:
Preset dosing, which means patients no longer have to set their dose each day
Dose confirmation screen that notifies patients when they have properly administered their treatment
Logging of the date and dose of each injection, which allows healthcare
professionals to monitor patient adherence.
Thursday, December 6th, 2007
1:00 PM - 1:15 PM ET
Downlink Freq. 4180 Horizontal
Preview and access this video on Pathfire DMG: Slug # 30005
Search within the PR Newswire or MultiVu section by story ID # 30005 or by headline
For technical assistance call Pathfire Customer Care at 1-888-345-0489
or e-mail email@example.com
NEWS: New Injection Device Available for Growth Hormone Therapy
FORMAT: News Package with Extra Soundbites and B-roll
ADDITIONAL RESOURCES: Video, contact information and more available at:
* 10-year-old child with growth hormone deficiency, and her mother
* Dr. Henry Anhalt, Director, Division of Pediatric Endocrinology, St.
Barnabas Medical Center
* Mary Andrews, CEO and Co-Founder of The Magic Foundation
* Jim Hoyes, Chief Commercial Officer, EMD Serono, Inc.
* easypod demo
* Lifestyle footage of patient & parent
* Doctor & Corporate spokesperson footage
VIDEO PROVIDED BY: EMD Serono, Inc.
Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations, 1-800-653-5313 EXT. 3
|SOURCE EMD Serono, Inc.|
Copyright©2007 PR Newswire.
All rights reserved